Endeavour Silver Corp (EXK) stock: A year of ups and downs

While Endeavour Silver Corp has overperformed by 3.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EXK rose by 40.62%, with highs and lows ranging from $5.67 to $2.46, whereas the simple moving average jumped by 22.88% in the last 200 days.

On March 21, 2025, Raymond James started tracking Endeavour Silver Corp (NYSE: EXK) recommending Outperform. BMO Capital Markets also rated EXK shares as ‘Outperform’, setting a target price of $6 on the company’s shares in an initiating report dated June 17, 2024. BMO Capital Markets initiated its ‘Market Perform’ rating for EXK, as published in its report on March 22, 2022. B. Riley FBR also rated the stock as ‘Buy’.

Analysis of Endeavour Silver Corp (EXK)

Further, the quarter-over-quarter increase in sales is 0.58%, showing a positive trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Endeavour Silver Corp’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -14.41% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.77, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and EXK is recording an average volume of 14.23M. On a monthly basis, the volatility of the stock is set at 3.76%, whereas on a weekly basis, it is put at 2.60%, with a loss of -0.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.85, showing growth from the present price of $4.95, which can serve as yet another indication of whether EXK is worth investing in or should be passed over.

How Do You Analyze Endeavour Silver Corp Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.25%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 39.02% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

EXK shares are owned by institutional investors to the tune of 39.02% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.